Research Article

[Retracted] Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia

Table 5

Adverse reactions [n (%)].

GroupnNausea and vomitingPulmonary infectionFeverLower PLTTotal

Treatment group102 (20.00)1 (10.00)1 (10.00)1 (10.00)5 (50.00)
Control group102 (20.00)1 (10.00)2 (20.00)1 (10.00)6 (60.00)
X20.202
0.653